Urease-based vaccine and treatment for helicobacter infection
US6290962A · kind A · utility
14Cited by
11References
72Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 1994 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Feb 23, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of eliciting in a mammalian host a protective immune response to Helicobacter infection and treatment of Helicobacter infection by administering to the host an immunogenically effective amount of a Helicobacter urease or urease subunits as antigen. Vaccine compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.